Print
Email
Bookmark
RSS
Clinical Trial For New Tuberculosis Vaccine
With annually 2 million
deaths and 9 million new
cases, there are more
victims of tuberculosis than
of any other infectious
disease, apart from AIDS.
Worsening the situation,
... > full story
Rifamycin Antibiotics Attack Tuberculosis Bacteria With Walls, Not Signals
Amid concerns about the
rising number of new
tuberculosis cases
worldwide, researchers have
reexamined and disproved a
... > full story
Synthetic Biology Is Bearing Fruit: Blockers Against Blockers
Synthetic Biology is bearing
fruit: the tuberculosis
pathogen can be fooled by a
widely used food additive.
The WHO records around nine
... > full story
Comprehensive Treatment Of Extensively Drug-resistant TB Works, Study Finds
XDR-TB has been reported in
49 countries throughout the
world. This study shows that
a comprehensive, ambulatory
management program can cure ... > full story
Browse News Stories
1 to 10 of 164 stories
view headlines only
-
HefA Plays An Important Role In Multidrug Resistance Of Helicobacter Pylori
September 19, 2008 — In recent years, the multidrug resistance strains of H. Pylori have already been discovered, which are simultaneously resistant to amoxicillin, metronidazole and clarithromycin. A research group ... > full story -
Method To Prevent Liver Damage Induced By Anti-tuberculosis Treatment?
September 19, 2008 — Anti-tuberculosis treatment is known to cause liver damage in 4 percent to 11 percent of patients mandating to stop the treatment till the liver enzymes come to normal. In ~0.1 percent cases this ... > full story -
Small Numbers Of Patients With Drug-resistant TB May Account For High Proportion Of New Infections
September 18, 2008 — Inadequate treatment of antibiotic-resistant tuberculosis can leave patients highly infectious, and small numbers of such patients may drive transmission of the disease in the very health care ... > full story -
Tuberculosis Drug Shows Promise Against Latent Bacteria
September 14, 2008 — A new study has shown that an investigational drug, R207910, is quite effective at killing latent bacteria. This revelation suggests that R207910 may lead to improved and shortened treatments for ... > full story -
Lack Of Tuberculosis Trials In Children Unacceptable, Experts Argue
August 20, 2008 — Ensuring the involvement of children in the evaluation of tuberculosis treatment is critical as we move forward in developing effective responses to active and drug-susceptible tuberculosis, argues a ... > full story -
Extensively Drug-resistant Tuberculosis Found In California
August 14, 2008 — In the first statewide study of extensively drug-resistant tuberculosis (XDR TB) in the United States, California officials have identified 18 cases of the dangerous and difficult-to-treat disease ... > full story -
Treatment Outcomes Highlight Dangers Of Extensively Drug-resistant Tuberculosis
August 7, 2008 — In a retrospective study of 174 tuberculosis patients, patients with extensively-drug-resistant tuberculosis were almost eight times as likely to die as patients with multi-drug resistant ... > full story -
Certain HIV Treatment Less Effective When Used With Anti-TB Therapy
August 6, 2008 — Patients receiving rifampicin-based anti-tuberculosis therapy are more likely to experience virological failure when starting nevirapine-based antiretroviral therapy, an HIV treatment that is widely ... > full story -
Strategies To Control TB Outdated, Inadequate, Analysis Shows
August 5, 2008 — The standard regimens to treat tuberculosis are inadequate in countries with high rates of multi-drug resistant TB. In countries with high rates of MDR-TB, patients are nearly twice as likely to fail ... > full story -
Potential New Drug Target To Fight Tuberculosis Identified
August 1, 2008 — With antibiotic resistance on the rise, tuberculosis is emerging as a bigger global health threat than ever before. But now, innovative research suggests that Mycobacterium tuberculosis has an as yet ... > full story
Search ScienceDaily
Number of stories in archives: 59,266
